A Practical and Quantitative Microtest for Determination of Neutralizing Antibodies against Epstein-Barr Virus Free

Abstract

Much information regarding the association of the Epstein-Barr virus (EBV) with infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma has been derived from serological test procedures, involving a number of distinct antigen-antibody systems related to EBV. These relationships have been recently reviewed (Henle & Henle, 1972).

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-18-3-385
1973-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/18/3/JV0180030385.html?itemId=/content/journal/jgv/10.1099/0022-1317-18-3-385&mimeType=html&fmt=ahah

References

  1. Durr F. E., Monroe J. H., Schmitter R., Traul K. A., Hirshaut Y. 1970; Studies on infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells. International Journal of Cancer 6:436–449
    [Google Scholar]
  2. Gergely L., Klein G., Ernberg I. 1971; Appearance of EBV-associated antigens in infected Raji cells. Virology 45:10–21
    [Google Scholar]
  3. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology 91:1248–1256
    [Google Scholar]
  4. Henle W., Henle G. 1972; Epstein-Barr virus: the cause of infectious mononucleosis. In Oncogenesis and Herpesviruses pp. 269–274 Edited by Biggs P. M., De-The G., Payne L. N. Lyon: International Agency for Research on Cancer;
    [Google Scholar]
  5. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M. R., Pike P., Tukei P., Ziegler J. 1969; Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. Journal of National Cancer Institute 43:1147–1157
    [Google Scholar]
  6. Henle G., Henle W., Klein G. 1971; Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. International Journal of Cancer 8:272–282
    [Google Scholar]
  7. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. 1970; Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science, New York 169:188–190
    [Google Scholar]
  8. Miller G., Niederman J. C., Stitt D. A. 1972; Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. Journal of Infectious Diseases 125:403–406
    [Google Scholar]
  9. Pearson G., Dewey F., Klein G., Henle G., Henle W. 1970; Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens induced by the virus. Journal of the National Cancer Institute 45:989–995
    [Google Scholar]
  10. Pulvertaft R. J. V. 1964; Cytology of Burkitt’s tumour (African lymphoma). Lancet 1:238–240
    [Google Scholar]
  11. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  12. Rocchi G., Hewetson J., Henle W., Henle G. 1973; Antigen expression and colony formation of lymphoblastoid cell lines after super-infection with Epstein-Barr virus. Journal of the National Cancer Institute (in the press)
    [Google Scholar]
  13. Sever J. L. 1962; Application of a microtechnique to viral serological investigations. Journal of Immunology 88:320–329
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-18-3-385
Loading
/content/journal/jgv/10.1099/0022-1317-18-3-385
Loading

Data & Media loading...

Most cited Most Cited RSS feed